Investors Research Corp Astrazeneca PLC Transaction History
Investors Research Corp
- $441 Million
- Q4 2024
A detailed history of Investors Research Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Investors Research Corp holds 2,020 shares of AZN stock, worth $146,914. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,020
Previous 2,020
-0.0%
Holding current value
$146,914
Previous $157,000
15.92%
% of portfolio
0.03%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,344Shares Held
478MCall Options Held
5.39MPut Options Held
3.79M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.57 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.98 Billion2.12% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.69 Billion0.46% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.68 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.42 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $225B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...